{
  "docId": "019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "docSlug": "61f4be21d1a97a93f2294133e3bf0c0f",
  "documentTitle": "Bausch Health Companies | Investor Conference Presentation Deck | 10 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 5,
  "pageCount": 10,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-ca7e-71d0-9b6d-c6cccc832e2e/5",
  "deckHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "deckJsonHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e.json",
  "deckAnchorHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.65
      },
      "kind": "list",
      "text": "Rifaximin timed release coated beads in capsules",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "625db7fa-96dc-4ea4-8c63-f2608795d2c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.23
      },
      "kind": "list",
      "text": "Rifaximin solid soluble dispersion (SSD) in a tablet",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "73857680-add0-435a-9538-ed9aa466bf22",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.37
      },
      "kind": "list",
      "text": "Combination of rifaximin with a mucolytic agent",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "844f7ed4-d694-442a-8588-ca1ffa386332",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.78,
        "x": 0.11,
        "y": 0.51
      },
      "kind": "list",
      "text": "Rifaximin liquid gel capsules",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e617b6a3-c10e-4a06-bb94-b1aec3b426fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "subtitle",
      "text": "Unique and novel rifaximin formulations are in development to address unmet medical needs",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64b3f7a6-0574-4851-b745-36c2c3258009",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "4 Novel Rifaximin Formulations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "619e13cc-4315-4030-9e3f-66b0249f09b4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "f6a4a7e6-5c0f-4742-a2a2-cfc9c845e6ee",
      "evidence": "list/bullet: Rifaximin solid soluble dispersion (SSD) in a tablet; Rifaximin timed release coated beads in capsules; Combination of rifaximin with a mucolytic agent",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "26a0baae-0573-4787-a96e-cf35b4858a66",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Amiselimod Capsules, Rifaximin Solid Soluble Dispersion (SSD) in a Tablet",
      "position": 1,
      "confidence": 0.6,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}